This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: City University of Hong Kong. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Likun Wei: Innovator in Antibody Fragment Production
Introduction
Likun Wei is a prominent inventor based in Hong Kong, China, known for his innovative work in the field of antibody fragment production. With a singular patent to his name, he has made significant contributions to biotechnology and immunology.
Latest Patents
Likun Wei holds a patent titled "Method of producing antibody fragment." This innovative method involves administering an immunizing mixture containing the target antigen to a cartilaginous fish multiple times. Afterward, a blood sample is collected from the fish, and RNAs are extracted from the sample. These RNAs are then subjected to reverse transcription to obtain complementary DNA, with the option to amplify the cDNA for better yield followed by purification. The patent also encompasses methods for producing antibody fragments from sharks, as well as kits and systems for determining the presence and/or amount of a target antigen in a sample.
Career Highlights
Currently, Likun Wei is affiliated with the City University of Hong Kong, where he continues to engage in research and innovation. His work has not only advanced scientific knowledge but also paved the way for new applications in diagnostics and therapeutics.
Collaborations
Throughout his career, Likun Wei has collaborated with notable colleagues, including Jiahai Shi and Lai Leo Chan. These partnerships contribute to a dynamic research environment, fostering inventions that have the potential to make a significant impact in their respective fields.
Conclusion
Likun Wei exemplifies how a single patent can reflect a wealth of knowledge and innovation in the field of biotechnology. His contributions underscore the importance of ongoing research and collaboration in pushing the boundaries of what is possible in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
